semaglutide and hormone replacement therapy GLP-1 Medication + Bioidentical Hormone

Retatrutide (Triple Agonist) Retatrutide (LY3437943) is Eli Lilly's investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously

Each of these drugs went through large-scale clinical trials before receiving FDA approval

Avoid Alcohol: Refrain from alcohol consumption for at least 24 hours before your treatment, as it can interfere with nutrient absorption

10.1152/ajpendo.00544.2001 117

Individuals with Poor Absorption: People with low stomach acid, or those who have had certain surgeries (like gastric bypass), may struggle to absorb B12 from food and would benefit from injections